ConMed buys rest of Imagyn's minimal access line
This article was originally published in Clinica
Executive Summary
ConMed is to buy the remainder of Imagyn Medical Technologies' minimal access surgery product line that it did not buy in November 2000. The stock transaction is valued at around $29.7 million.